Text
Microbiota-targeted approaches that boost specific SCFAs could help prevent harmful Candida overgrowth in vulnerable people.
Targeting TLR5 could offer a new way to treat or prevent IPF by correcting harmful lung microbiota changes after injury.
Industry, Gastroenterology
Sponsored by
Humiome® B2 uses a patented coating technology intended to transport riboflavin through the upper gastrointestinal tract and release most of it in the ileal-colonic region.
Tumor microbiotas appear mainly in cancers of the mouth and digestive tract.
Diabetes prevention needs to account for diet-microbiota interactions, because some gut microbes appear to predict diabetes risk differently depending on fiber intake.
Monitoring or reshaping the gut microbiota after adenoma removal could become part of future strategies to reduce colorectal cancer risk.
Repeated head impacts, even if minor, can have biological effects.
The results may inform programs to preserve microbial diversity while delivering essential care.
Targeting deoxycholic acid (DCA)-producing gut bacteria could be a way to slow breast cancer progression.
Microbiota-derived molecules such as IPA may offer a way to strengthen early-life immunity against respiratory viruses.
